# BugSigDB 2021-12-19, License: Creative Commons Attribution 4.0 International, URL: https://bugsigdb.org
bsdb:1/2/1_hyperplastic-polyp:hyperplastic-polyp-cases_vs_controls_UP	NA	57037
bsdb:6/1/1_non-alcoholic-fatty-liver-disease:advanced-fibrosis_vs_mild/moderate-fibrosis_DOWN	NA	39491
bsdb:7/1/2_autism:severely-autistic_vs_non-sibling-control_DOWN	NA	1535
bsdb:9/1/1_breast-carcinoma:Breast-Cancer_vs_Control_UP	NA	1766
bsdb:9/1/2_breast-carcinoma:Breast-Cancer_vs_Control_DOWN	NA	33917
bsdb:10/2/1_cervical-glandular-intraepithelial-neoplasia:Cervical-Intraepithelial-Lesion-HIV-patients_vs_Normal-tissue-HIV-patients_UP	NA	215580
bsdb:11/1/1_cervical-glandular-intraepithelial-neoplasia:HIV-patients-with-lesion-at-12-months_vs_HIV-pateints-with-normal-tissue-at-6-months_DOWN	NA	2702
bsdb:12/1/1_human-papilloma-virus-infection:HPV-persistent_vs_HPV-clearance_UP	NA	387661
bsdb:12/2/1_human-papilloma-virus-infection:HPV-clearance_vs_HPV-negative_UP	NA	2130
bsdb:12/3/1_human-papilloma-virus-infection:HPV-negative_vs_HPV-presistent-and-clearance_UP	NA	47770
bsdb:12/4/1_human-papilloma-virus-infection:HPV-clearance_vs_HPV-presistent-and-negative_UP	NA	39485
bsdb:13/1/1_cervical-glandular-intraepithelial-neoplasia:Cervical-Intraepithelial-Neoplasis-+2_vs_Cervical-Intraepithelial-Neoplasis--1_UP	NA	827
bsdb:13/1/2_cervical-glandular-intraepithelial-neoplasia:Cervical-Intraepithelial-Neoplasis-+2_vs_Cervical-Intraepithelial-Neoplasis--1_DOWN	NA	82135
bsdb:13/2/1_cervical-glandular-intraepithelial-neoplasia:HPV-+ve_vs_HPV--ve-among-pateints-with-Cervical-Intraepithelial-Neoplasia-different-severity-status_UP	NA	1261
bsdb:13/2/2_cervical-glandular-intraepithelial-neoplasia:HPV-+ve_vs_HPV--ve-among-pateints-with-Cervical-Intraepithelial-Neoplasia-different-severity-status_DOWN	NA	1584
bsdb:16/2/2_obesity:high-fat-diet-+-melatonin_vs_high-fat-diet_DOWN	NA	152490
bsdb:17/1/2_anxiety-disorder:treatment-active-Generalized-Anxiety-disorder_vs_healthy-controls_DOWN	NA	39491
bsdb:17/2/2_anxiety-disorder:treatment-naiive-Generalized-Anxiety-disorder_vs_healthy-controls_DOWN	NA	39491
bsdb:18/1/1_obesity:Sv129--Low-Fat_vs_BL6--Low-Fat_UP	NA	49118
bsdb:18/1/2_obesity:Sv129--Low-Fat_vs_BL6--Low-Fat_DOWN	NA	1735
bsdb:18/2/1_obesity:Sv129-High-Fat-without-enomithacin_vs_BL6-High-Fat-without-enomithacin_UP	NA	49118
bsdb:18/2/2_obesity:Sv129-High-Fat-without-enomithacin_vs_BL6-High-Fat-without-enomithacin_DOWN	NA	1735
bsdb:18/3/2_obesity:Sv129-High-Fat-with-enomithacin_vs_BL6-High-Fat-with-enomithacin_DOWN	NA	89152
bsdb:22/1/1_parkinson's-disease:Parkinson's_vs_Healthy-controls_UP	NA	100176
bsdb:22/1/2_parkinson's-disease:Parkinson's_vs_Healthy-controls_DOWN	NA	33043
bsdb:26/1/1_sex-design:female_vs_male_UP	NA	47678
bsdb:26/1/2_sex-design:female_vs_male_DOWN	NA	310297
bsdb:26/2/2_obesity:BMI->33-female_vs_male_DOWN	NA	310297
bsdb:31/1/1_chronic-fatigue-syndrome:CFS/ME-patients_vs_controls_UP	NA	100884
bsdb:31/1/2_chronic-fatigue-syndrome:CFS/ME-patients_vs_controls_DOWN	NA	1971605
bsdb:31/2/2_chronic-fatigue-syndrome:CFS/ME-patients-with-IBS_vs_controls_DOWN	NA	40520
bsdb:31/3/1_chronic-fatigue-syndrome:CFS/ME-patients-without-IBS_vs_controls_UP	NA	1506
bsdb:32/1/1_anorexia-nervosa:Aonerxia-Nervosa-patients_vs_Controls_UP	NA	2173
bsdb:33/1/1_obesity:obese_vs_controls_UP	NA	40520
bsdb:36/1/1_obesity:obese-adolescent_vs_control-adult_UP	NA	1747
bsdb:36/6/1_obesity:obese-adult_vs_control-adult_UP	NA	1747
bsdb:38/1/1_body-odor-measurement:teen-head_vs_child-head_UP	NA	1747
bsdb:38/1/2_body-odor-measurement:teen-head_vs_child-head_DOWN	NA	1282
bsdb:38/2/1_body-odor-measurement:teen-neck_vs_child-neck_UP	NA	76773
bsdb:38/2/2_body-odor-measurement:teen-neck_vs_child-neck_DOWN	NA	1290
bsdb:38/3/1_body-odor-measurement:teen-underarm_vs_child-underarm_UP	NA	76773
bsdb:38/3/2_body-odor-measurement:teen-underarm_vs_child-underarm_DOWN	NA	1290
bsdb:39/1/1_body-odor-measurement:youth-underarm-before_vs_after-excercise_UP	NA	1282
bsdb:39/2/1_body-odor-measurement:youth-Neck-before_vs_after-excercise_DOWN	NA	108981
bsdb:41/1/1_psychosis:FIrst-episode-Psychosis_vs_Controls_UP	NA	1689
bsdb:41/1/2_psychosis:FIrst-episode-Psychosis_vs_Controls_DOWN	NA	115778
bsdb:43/1/2_behcet's-syndrome:behcet's-disease_vs_controls_DOWN	NA	76123
bsdb:43/2/1_behcet's-syndrome:immunosuppressant-users_vs_non-immunosuppressent-users-among-behcet's-patients_UP	NA	41976
bsdb:43/2/2_behcet's-syndrome:immunosuppressant-users_vs_non-immunosuppressent-users-among-behcet's-patients_DOWN	NA	1969407
bsdb:44/1/1_obesity:pediatric-obese_vs_controls_UP	NA	853
bsdb:44/1/2_obesity:pediatric-obese_vs_controls_DOWN	NA	46506
bsdb:46/1/1_obesity:pediatric-obese_vs_controls_DOWN	NA	1853550
bsdb:51/1/2_colorectal-cancer:Carcinoma-patients_vs_postoperation-patients_DOWN	NA	33038
bsdb:59/1/2_titanium-dioxide-nanoparticle:pregnant-rats-exposed-to-titanium-dioxide-nanoparticles_vs_control-pregnant-rats-at-gestational-day-10_DOWN	NA	234266
bsdb:61/2/1_obesity:infants-of-overweight-mothers_vs_infants-of-normal-weight-mother-at-age-6-month_UP	NA	1686
bsdb:61/4/1_obesity:infants-of-excessive-maternal-weight-gain-mothers_vs_infants-of-normal-maternal-weight-gain-mothers-at-age-6-months_UP	NA	1498
bsdb:62/1/1_cesarean-section:C-section-delivery_vs_vaginal-delivery-in-mecomium_DOWN	NA	1596
bsdb:63/1/1_cesarean-section:C-section-delivery_vs_vaginal-delivery-after-7-days-of-delivery_DOWN	NA	1596
bsdb:63/3/1_cesarean-section:C-section-delivery_vs_vaginal-delivery-after-6-months-of-delivery_DOWN	NA	1598
bsdb:64/1/1_periodontitis:periodnotitis_vs_No-Periodontitis-within-negative-diabetic-background-only_UP	NA	1302
bsdb:64/1/2_periodontitis:periodnotitis_vs_No-Periodontitis-within-negative-diabetic-background-only_DOWN	NA	1924944
bsdb:64/2/2_type-II-diabetes-mellitus:Diabetic_vs_Non-diabetic-within-negative--periodnotitis_DOWN	NA	1018
bsdb:64/3/1_type-II-diabetes-mellitus:Diabetic_vs_Non-diabetic-within-positive--periodnotitis_UP	NA	1019
bsdb:64/4/1_periodontitis:periodnotitis_vs_No-Periodontitis-within-positive-diabetic-background-only_UP	NA	143361
bsdb:64/5/2_periodontitis:periodnotitis_vs_No-Periodontitis-within-both-positive-and-negative-diabetic-background_DOWN	NA	1655
bsdb:66/2/1_neonatal-jaundice:infants-with-jaundice_vs_control_UP	NA	1502
bsdb:70/2/1_obesity:female-pediatric-obese_vs_female-pediatric-normal-weight_UP	NA	28111
bsdb:70/3/1_obesity:male-pediatric-obese_vs_male-pediatric-normal-weight_UP	NA	28111
bsdb:70/3/2_obesity:male-pediatric-obese_vs_male-pediatric-normal-weight_DOWN	NA	310297
bsdb:74/1/1_obesity:obese_vs_non-obese_UP	NA	39486
bsdb:74/2/1_obesity:obese_vs_Nonobese-microbiota-cluster_UP	NA	39488
bsdb:74/2/2_obesity:obese_vs_Nonobese-microbiota-cluster_DOWN	NA	119853
bsdb:74/3/2_obesity:high-BMI_vs_low-BMI_DOWN	NA	511
bsdb:74/4/1_obesity:high-C-Reactive-Protein_vs_low-C-Reactive-Protein_UP	NA	29370
bsdb:79/1/1_obesity:Laparoscopic-sleeve-gastrectomy-baseline_vs_Laparoscopic-sleeve-gastrectomy-after-3-months-and-6-Months-combined_UP	NA	88431
bsdb:79/2/1_obesity:Very-low-calorie-diet-baseline_vs_very-low-calorie-diet-after-3-months-and-6-months_DOWN	NA	100884
bsdb:81/1/2_obesity:3-Months-after-Roux-en-Y-gastric-bypass-surgery_vs_baseline_DOWN	NA	853
bsdb:82/1/1_obesity:before-surgery_vs_lean-controls_UP	NA	853
bsdb:82/1/2_obesity:before-surgery_vs_lean-controls_DOWN	NA	860
bsdb:84/1/1_obesity:after-surgery_vs_lean-controls_UP	NA	621
bsdb:84/1/2_obesity:after-surgery_vs_lean-controls_DOWN	NA	833
bsdb:88/1/2_schizophrenia:schizophrenia_vs_non-psychiatric-controls_DOWN	NA	729
bsdb:91/1/1_cesarean-section:C-section-delivery_vs_vaginal-delivery_UP	NA	39491
bsdb:94/1/1_obesity:3-months_vs_baseline-participants_UP	NA	469610
bsdb:94/1/2_obesity:3-months_vs_baseline-participants_DOWN	NA	651822
bsdb:94/2/1_obesity:6-months_vs_3-months-participants_UP	NA	81462
bsdb:94/2/2_obesity:6-months_vs_3-months-participants_DOWN	NA	469610
bsdb:94/3/1_obesity:24-months_vs_6-months-participants_UP	NA	984
bsdb:94/3/2_obesity:24-months_vs_6-months-participants_DOWN	NA	74426
bsdb:96/1/1_obesity:obese_vs_controls_UP	NA	649756
bsdb:96/1/2_obesity:obese_vs_controls_DOWN	NA	290055
bsdb:97/3/1_obesity:obese-patients-three-months-after-Sleeve-gastrectomy-SG3_vs_obese-patients-prior-to-Sleeve-gastrectomy-SG0_DOWN	NA	214856
bsdb:97/4/2_obesity:obese-patients-3-moths-after-Roux-en-Y-gastric-bypass-RYGB3_vs_patients-prior-to-Roux-en-Y-gastric-bypass-RYGB0_DOWN	NA	1308
bsdb:99/1/1_obesity:obese_vs_controls_UP	NA	39488
bsdb:101/1/2_obesity:obese_vs_lean-controls_DOWN	NA	1590
bsdb:108/1/1_anorexia-nervosa:anorexia-nervosa-patients_vs_healthy-controls_DOWN	NA	1590
bsdb:113/1/1_unipolar-depression:MDD_vs_controls_DOWN	NA	1603
bsdb:115/1/1_unipolar-depression:MDD_vs_controls_UP	NA	1689
bsdb:115/1/2_unipolar-depression:MDD_vs_controls_DOWN	NA	729
bsdb:115/2/1_bipolar-disorder:bipolar_vs_healthy-controls_DOWN	NA	290053
bsdb:119/1/2_type-II-diabetes-mellitus:Metaformin-positive_vs_Metaformin-negative-among-Opoid-negative_DOWN	NA	47678
bsdb:120/1/2_physical-activity:Activity-Based-Anorexia-group_vs_exercise-group_DOWN	NA	39491
bsdb:120/2/2_physical-activity:Ad-libitum-group_vs_exercise-group_DOWN	NA	39491
bsdb:121/1/1_gingivitis:gingivitis_vs_healthy-controls_UP	NA	241556
bsdb:122/1/2_breast-carcinoma:tumor-tissue_vs_normal-tissue_DOWN	NA	257758
bsdb:124/1/1_diet:body-builders-(high-protein)_vs_distance-runners-(high-carb)_UP	NA	550
bsdb:131/6/1_diet:Cara-Cara_vs_Bahia-at-time-7_UP	NA	1263076
bsdb:134/2/2_diet:6-months-after--New-Nordic-Diet_vs_before--New-Nordic-Diet_DOWN	NA	2173
bsdb:136/2/2_diet:two-weeks-after-a-dietry-intervention_vs_before-dietary-intervention_DOWN	NA	39492
bsdb:139/4/2_squamous-cell-carcinoma:Oral-cavity-cancer-cases_vs_controls_DOWN	NA	490
bsdb:145/1/1_oral-squamous-cell-carcinoma:oral-squamous-cell-carcinoma-(OSCC)_vs_Controls_UP	NA	1018
bsdb:145/1/2_oral-squamous-cell-carcinoma:oral-squamous-cell-carcinoma-(OSCC)_vs_Controls_DOWN	NA	467210
bsdb:150/2/1_head-and-neck-carcinoma:Cancer_vs_Vocal-cord-polyp_UP	NA	351
bsdb:151/1/1_breast-cancer:Postmenopausal-breast-cancer-patients_vs_controls_UP	NA	24
bsdb:151/1/2_breast-cancer:Postmenopausal-breast-cancer-patients_vs_controls_DOWN	NA	1633
bsdb:152/2/1_cervical-cancer:cervical-cancer_vs_healthy-controls_UP	NA	46506
bsdb:155/2/1_esophageal-cancer:Esophageal-Squamous-cell-carcinoma-(ESCC)_vs_controls_UP	NA	69710
bsdb:155/2/2_esophageal-cancer:Esophageal-Squamous-cell-carcinoma-(ESCC)_vs_controls_DOWN	NA	732
bsdb:159/2/2_gingival-disease:3-months-after-the-placement-of-the-brackets_vs_before_DOWN	NA	1077464
bsdb:167/1/1_squamous-cell-carcinoma:Stage-4_vs_healthy-controls_UP	NA	1872471
bsdb:167/1/2_squamous-cell-carcinoma:Stage-4_vs_healthy-controls_DOWN	NA	46124
bsdb:167/2/1_squamous-cell-carcinoma:Stage-1_vs_healthy-controls_UP	NA	205
bsdb:167/2/2_squamous-cell-carcinoma:Stage-1_vs_healthy-controls_DOWN	NA	28037
bsdb:167/3/2_squamous-cell-carcinoma:Stage-2-&-3_vs_healthy-controls_DOWN	NA	28037
bsdb:169/1/1_gastric-cancer:white-thin-tongue-coating-GC-patient_vs_other-coatings_UP	NA	187326
bsdb:169/1/2_gastric-cancer:white-thin-tongue-coating-GC-patient_vs_other-coatings_DOWN	NA	142586
bsdb:169/2/1_gastric-cancer:white-thick-tongue-coating-GC-patient_vs_other-coatings_UP	NA	439703
bsdb:169/2/2_gastric-cancer:white-thick-tongue-coating-GC-patient_vs_other-coatings_DOWN	NA	1624
bsdb:169/3/1_gastric-cancer:yellow-thick-tongue-coating-GC-patient_vs_other-coatings_DOWN	NA	729
bsdb:171/2/1_tongue-neoplasm:tongue/pharylgeal-cancer_vs_controls_UP	NA	1305
bsdb:171/2/2_tongue-neoplasm:tongue/pharylgeal-cancer_vs_controls_DOWN	NA	28132
bsdb:171/3/2_esophageal-cancer:esophageal-cancer_vs_controls_DOWN	NA	28132
bsdb:171/4/1_colorectal-cancer:colorectal-cancer_vs_controls_UP	NA	237576
bsdb:171/4/2_colorectal-cancer:colorectal-cancer_vs_controls_DOWN	NA	28132
bsdb:171/5/1_gastric-cancer:gastric-cancer_vs_controls_UP	NA	837
bsdb:171/5/2_gastric-cancer:gastric-cancer_vs_controls_DOWN	NA	1924944
bsdb:182/1/1_acetaldehyde:high-acetaldehyde-concentration-group_vs_low-acetaldehyde-concentration-group_UP	NA	484
bsdb:182/1/2_acetaldehyde:high-acetaldehyde-concentration-group_vs_low-acetaldehyde-concentration-group_DOWN	NA	470565
bsdb:183/1/1_Crohn's-disease:crohn-disease-ASCA-positive-patients_vs_crohn-disease-ASCA-negative-patients_UP	NA	33039
bsdb:183/1/2_Crohn's-disease:crohn-disease-ASCA-positive-patients_vs_crohn-disease-ASCA-negative-patients_DOWN	NA	853
bsdb:188/1/2_cervical-cerclage:Vaginal-microbiome-of-symptomatic-women-prior-ro-cerclage_vs_Vaginal-microbiome-of-asymptomatic-women-prior-to-cerclage_DOWN	NA	47770
bsdb:191/1/1_equol:equol-producers_vs_equol-non-producers_UP	NA	572010
bsdb:194/1/1_ovarian-cancer:ovarian-cancer_vs_normal-tissue_UP	NA	1364
bsdb:194/1/2_ovarian-cancer:ovarian-cancer_vs_normal-tissue_DOWN	NA	330920
bsdb:196/1/2_Henoch-Schoenlein-purpura:Henoch-Schönlein-Purpura_vs_controls_DOWN	NA	39491
bsdb:202/2/1_autism:children-with-autism-non-mental-regression-ANMR_vs_healthy-control_UP	NA	208479
bsdb:202/3/1_autism:children-with-autism-mental-regression-AMR_vs_healthy-control_UP	NA	208479
bsdb:205/1/1_human-papilloma-virus-infection:HPV-positive_vs_HPV-negative_UP	NA	2702
bsdb:206/1/1_gastric-cancer:patients-diagnosed-with-gastric-cancer_vs_patients-diagnosed-with-gastritis_UP	NA	1318
bsdb:213/1/1_diet:low-fiber-(Q1-and-Q2)_vs_high-fiber-(Q3-and-Q4)_UP	NA	31971
bsdb:213/2/1_diet:low-fiber-from-FRUITS/VEGETABLES-(Q1-and-Q2)_vs_high-fiber-from-FRUITS/VEGETABLES-(Q3-and-Q4)_UP	NA	820
bsdb:213/3/1_diet:low-fiber-from-BEANS-(Q1-and-Q2)_vs_high-fiber-from-BEANS-(Q3-and-Q4)_UP	NA	31971
bsdb:213/3/2_diet:low-fiber-from-BEANS-(Q1-and-Q2)_vs_high-fiber-from-BEANS-(Q3-and-Q4)_DOWN	NA	853
bsdb:216/1/1_cesarean-section:C-section_vs_vaginal-delivery_DOWN	NA	1502
bsdb:217/1/1_eczema:child-with-eczema_vs_healthy-control_UP	NA	29343
bsdb:217/3/2_age:infant-at-18-months_vs_infant-at-6-months_DOWN	NA	1590
bsdb:219/1/1_diet:lower-fiber-(cracker)_vs_higher-fiber-(almonds)---interaction-by-time_UP	NA	817
bsdb:221/1/1_Urinary-tract-infection:urinary-tract-infection_vs_healthy-controls_UP	NA	536633
bsdb:221/1/2_Urinary-tract-infection:urinary-tract-infection_vs_healthy-controls_DOWN	NA	1537
bsdb:222/1/1_gastric-cancer:high-gastric-cancer-risk_vs_low-gastric-cancer-risk-patients_UP	NA	1926307
bsdb:222/1/2_gastric-cancer:high-gastric-cancer-risk_vs_low-gastric-cancer-risk-patients_DOWN	NA	1310087
bsdb:223/2/1_HIV-infection:HIV-infected-homosexual-patients_vs_healthy-controls_UP	NA	1547
bsdb:223/3/1_HIV-infection:Intravenous-drug-abuse-HIV-patients_vs_healthy-controls_UP	NA	33038
bsdb:223/5/1_HIV-infection:HAART_vs_healty-control_UP	NA	817
bsdb:224/1/1_diet:barley-(WGB)_vs_baseline_UP	NA	39491
bsdb:228/1/1_diet:day-3-of-PECTIN-spike-in_vs_day-6-of-PECTIN-spike-in_DOWN	NA	853
bsdb:228/2/1_diet:day-3-of-INULIN-spike-in_vs_day-6-of-INULIN-spike-in_DOWN	NA	853
bsdb:234/1/1_atopic-eczema:adult-with-atopic-dermatitis_vs_healthy-control_UP	NA	1280
bsdb:234/1/2_atopic-eczema:adult-with-atopic-dermatitis_vs_healthy-control_DOWN	NA	1747
bsdb:234/2/1_psoriasis:adult-with-psoriasis_vs_healthy-control_UP	NA	1872515
bsdb:234/2/2_psoriasis:adult-with-psoriasis_vs_healthy-control_DOWN	NA	1909303
bsdb:235/1/1_food-allergy:child-with-food-allergy_vs_healthy-control_UP	NA	1971605
bsdb:235/1/2_food-allergy:child-with-food-allergy_vs_healthy-control_DOWN	NA	1955243
bsdb:235/2/2_food-allergy:child-with-food-allergy_vs_healthy-sibling_DOWN	NA	1872444
bsdb:235/3/1_food-allergy:healthy-sibling_vs_healthy-control_UP	NA	1872444
bsdb:235/3/2_food-allergy:healthy-sibling_vs_healthy-control_DOWN	NA	1955243
bsdb:241/1/1_iron-deficiency-anemia:iron-deficiency-anemia_vs_healthy-control_UP	NA	137838
bsdb:243/1/2_gastric-cancer:current-H.pyloriI-infection_vs_non-current-H.pylori-infection_DOWN	NA	1833
bsdb:243/2/1_gastric-cancer:current-H.pyloriI-infection_vs_past-H.pylori-infection_UP	NA	820
bsdb:243/3/1_gastric-cancer:past-H.pylori-infection_vs_H.pylori-negative_DOWN	NA	820
bsdb:243/4/1_gastric-cancer:gastritis_vs_normal_UP	NA	562
bsdb:244/1/1_age:18-62-years_vs_2-12-years_UP	NA	1282
bsdb:244/1/2_age:18-62-years_vs_2-12-years_DOWN	NA	1306
bsdb:244/4/1_age:18-62-years_vs_2-12-years_UP	NA	147802
bsdb:244/5/1_atopic-eczema:lesional-skin_vs_non-lesional-skin_UP	NA	1280
bsdb:244/6/1_atopic-eczema:lesional-skin_vs_non-lesional-skin_UP	NA	1280
bsdb:244/7/1_age:18-62-years_vs_2-12-years_UP	NA	147802
bsdb:244/7/2_age:18-62-years_vs_2-12-years_DOWN	NA	45634
bsdb:244/7/3_age:18-62-years_vs_2-12-years_UP	NA	147802
bsdb:244/7/4_age:18-62-years_vs_2-12-years_DOWN	NA	45634
bsdb:249/2/2_hepatitis,-alcoholic:HDC_vs_NAC_DOWN	NA	351
bsdb:249/3/2_hepatitis,-alcoholic:MAH_vs_NAC_DOWN	NA	351
bsdb:250/1/1_severe-aplastic-anemia:hematopoietic-stem-cell-transplantation-engraftment_vs_baseline_UP	NA	28129
bsdb:250/2/1_severe-aplastic-anemia:hematopoietic-stem-cell-transplantation-engraftment_vs_baseline_DOWN	NA	425941
bsdb:250/3/1_severe-aplastic-anemia:hematopoietic-stem-cell-transplantation-100-days-after-the-transplant_vs_engraftment_UP	NA	84135
bsdb:250/4/1_severe-aplastic-anemia:hematopoietic-stem-cell-transplantation-100-days-after-the-transplant_vs_engraftment_DOWN	NA	43675
bsdb:256/1/1_gastric-cancer:peritumoral-tissues_vs_normal-tissues_UP	NA	239935
bsdb:256/1/2_gastric-cancer:peritumoral-tissues_vs_normal-tissues_DOWN	NA	1396
bsdb:256/2/1_gastric-cancer:tumoral-tissues_vs_peritumoral-tissues_UP	NA	1396
bsdb:256/2/2_gastric-cancer:tumoral-tissues_vs_peritumoral-tissues_DOWN	NA	210
bsdb:256/3/1_gastric-cancer:tumoral-tissues_vs_normal-tissues_UP	NA	239935
bsdb:256/3/2_gastric-cancer:tumoral-tissues_vs_normal-tissues_DOWN	NA	820
bsdb:256/4/1_gastric-cancer:early-stage-tumor_vs_early-stage-normal_UP	NA	1328
bsdb:256/4/2_gastric-cancer:early-stage-tumor_vs_early-stage-normal_DOWN	NA	172044
bsdb:256/5/1_gastric-cancer:early-stage-peritumor_vs_early-stage-normal_DOWN	NA	172044
bsdb:256/6/1_gastric-cancer:late-stage-tumor_vs_late-stage-normal_UP	NA	1328
bsdb:256/7/1_gastric-cancer:late-stage-tumor_vs_late-stage-normal_DOWN	NA	172044
bsdb:256/8/1_gastric-cancer:late-stage-peritumor_vs_late-stage-normal_DOWN	NA	165179
bsdb:259/1/1_atopic-eczema:emollient-use_vs_no-emollient-use_UP	NA	1304
bsdb:259/2/1_atopic-eczema:emollient-use_vs_no-emollient-use_UP	NA	1304
bsdb:259/2/2_atopic-eczema:emollient-use_vs_no-emollient-use_UP	NA	1304
bsdb:261/1/1_chronic-pancreatitis:chronic-pancreatitis_vs_autoimmune-pancreatitis-type-1_UP	NA	460384
bsdb:265/1/1_human-papilloma-virus-infection:two-months_vs_at-birth_UP	NA	43675
bsdb:265/3/1_human-papilloma-virus-infection:HPV+_vs_HPV--at-two-months_DOWN	NA	39778
bsdb:267/1/1_atopic-asthma:atopic-asthma_vs_healthy-control_UP	NA	147802
bsdb:267/1/2_atopic-asthma:atopic-asthma_vs_healthy-control_DOWN	NA	57037
bsdb:267/2/1_atopic-asthma:atopic-no-asthma_vs_healthy-control_UP	NA	727
bsdb:267/2/2_atopic-asthma:atopic-no-asthma_vs_healthy-control_DOWN	NA	57037
bsdb:267/3/1_atopic-asthma:atopic-asthma_vs_atopic-no-asthma_UP	NA	28131
bsdb:267/3/2_atopic-asthma:atopic-asthma_vs_atopic-no-asthma_DOWN	NA	57037
bsdb:267/4/2_atopic-asthma:inhaled-corticosteroid-responder_vs_nonresponder_DOWN	NA	351
bsdb:269/1/1_leukemia:Acute-Lymphoblastic-Leukemia-diagnosis-and-Pre--Chemotherapy-treatment_vs_healthy-control_UP	NA	817
bsdb:271/1/2_acute-lymphoblastic-leukemia:Minimal-Residual-Disease--(negativity)-with-Allogenic-Stem-Cell-Transplant_vs_Minimal-Residual-Disease--(positivity)-with-Allogenic-Stem-Cell-Transplant_DOWN	NA	1335
bsdb:271/3/1_acute-lymphoblastic-leukemia:Minimal-Residual-Disease--(negativity)-with-Allogenic-Stem-Cell-Transplant_vs_Minimal-Residual-Disease--(positivity)-with-Allogenic-Stem-Cell-Transplant_UP	NA	853
bsdb:271/4/1_acute-lymphoblastic-leukemia:males_vs_female_UP	NA	853
bsdb:271/5/1_acute-lymphoblastic-leukemia:Minimal-Residual-Disease--(negativity)-with-Allogenic-Stem-Cell-Transplant_vs_Minimal-Residual-Disease--(positivity)-with-Allogenic-Stem-Cell-Transplant_UP	NA	39488
bsdb:271/6/1_acute-lymphoblastic-leukemia:Age-less-than-65-years-old_vs_Age-greater-than-65-years-old_UP	NA	39488
bsdb:273/1/1_acute-lymphoblastic-leukemia:Infectious-complications-(IC)_vs_non-infectious-complications-(NIC)_UP	NA	853
bsdb:273/1/2_acute-lymphoblastic-leukemia:Infectious-complications-(IC)_vs_non-infectious-complications-(NIC)_DOWN	NA	853
bsdb:273/2/1_acute-lymphoblastic-leukemia:Infectious-complications-(IC)_vs_non-infectious-complications-(NIC)_DOWN	NA	293
bsdb:273/2/2_acute-lymphoblastic-leukemia:Infectious-complications-(IC)_vs_non-infectious-complications-(NIC)_DOWN	NA	358
bsdb:274/1/2_human-papilloma-virus-infection:HPV+_vs_HPV-_DOWN	NA	1596
bsdb:274/2/1_cervical-glandular-intraepithelial-neoplasia:low-grade-dysplasia_vs_HPV-_UP	NA	82135
bsdb:274/2/2_cervical-glandular-intraepithelial-neoplasia:low-grade-dysplasia_vs_HPV-_DOWN	NA	47770
bsdb:274/3/2_cervical-glandular-intraepithelial-neoplasia:high-grade-dysplasia_vs_HPV-_DOWN	NA	1596
bsdb:274/4/1_cervical-cancer:invasive-cervical-carcinoma_vs_HPV-_UP	NA	40543
bsdb:274/4/2_cervical-cancer:invasive-cervical-carcinoma_vs_HPV-_DOWN	NA	47770
bsdb:274/6/1_cervical-glandular-intraepithelial-neoplasia:low-grade-dysplasia_vs_HPV-_UP	NA	1596
bsdb:274/6/2_cervical-glandular-intraepithelial-neoplasia:low-grade-dysplasia_vs_HPV-_DOWN	NA	47770
bsdb:274/7/2_cervical-glandular-intraepithelial-neoplasia:high-grade-dysplasia_vs_HPV-_DOWN	NA	59505
bsdb:274/8/1_cervical-cancer:invasive-cervical-carcinoma_vs_HPV-_DOWN	NA	28125
bsdb:274/9/1_human-papilloma-virus-infection,cervical-cancer:normal-pH_vs_abnormal-pH_UP	NA	1311
bsdb:274/9/2_human-papilloma-virus-infection,cervical-cancer:normal-pH_vs_abnormal-pH_DOWN	NA	1596
bsdb:274/10/1_human-papilloma-virus-infection:Hispanic_vs_non-Hispanic_UP	NA	1328
bsdb:274/10/2_human-papilloma-virus-infection:Hispanic_vs_non-Hispanic_DOWN	NA	1596
bsdb:276/2/1_multiple-myeloma:Multiple-Myeloma-patient_vs_healthy-control_UP	NA	28141
bsdb:276/4/1_multiple-myeloma:Multiple-Myeloma-patient_vs_healthy-relatives-control_UP	NA	287
bsdb:280/1/2_cervical-glandular-intraepithelial-neoplasia:high-grade-squamus-intraepithelial-lesion_vs_low-grade-squamus-intraepithelial-lesion_DOWN	NA	181675
bsdb:283/1/1_human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	1633
bsdb:283/1/2_human-papilloma-virus-infection:HPV+_vs_HPV-_DOWN	NA	47770
bsdb:284/2/1_chronic-kidney-disease:Chronic-kidney-disease_vs_healthy-controls_UP	NA	200
bsdb:284/3/1_chronic-kidney-disease:Chronic-kidney-disease_vs_healthy-controls_DOWN	NA	192066
bsdb:284/4/1_chronic-kidney-disease:Chronic-kidney-disease_vs_healthy-controls_UP	NA	1309
bsdb:285/1/2_multiple-sclerosis:pediatric-multiple-sclerosis_vs_healthy-controls_DOWN	NA	1261
bsdb:285/3/1_multiple-sclerosis:IMD-naive-cases-multiple-sclerosis_vs_healthy-controls_UP	NA	33038
bsdb:287/1/1_human-papilloma-virus-infection:Visit-1-HPV-(progression)_vs_HPV-(clearance)_UP	NA	1660
bsdb:287/1/2_human-papilloma-virus-infection:Visit-1-HPV-(progression)_vs_HPV-(clearance)_DOWN	NA	147802
bsdb:287/2/1_human-papilloma-virus-infection:Visit-2-HPV-(progression)_vs_HPV-(clearance)_UP	NA	33043
bsdb:287/2/2_human-papilloma-virus-infection:Visit-2-HPV-(progression)_vs_HPV-(clearance)_DOWN	NA	544581
bsdb:290/2/1_oral-mucositis:pre--and-three-month-after-auto-stem-cell-transplant_vs_one-and-two-weeks-after-stem-cell-transplant_UP	NA	1926307
bsdb:290/2/2_oral-mucositis:pre--and-three-month-after-auto-stem-cell-transplant_vs_one-and-two-weeks-after-stem-cell-transplant_DOWN	NA	230143
bsdb:290/3/1_oral-mucositis:pre--and-three-month-after-auto-stem-cell-transplant_vs_one-and-two-weeks-after-stem-cell-transplant_UP	NA	84135
bsdb:290/3/2_oral-mucositis:pre--and-three-month-after-auto-stem-cell-transplant_vs_one-and-two-weeks-after-stem-cell-transplant_DOWN	NA	1351
bsdb:291/1/1_graves-disease:graves-disease_vs_healthy-controls_UP	NA	582
bsdb:291/1/2_graves-disease:graves-disease_vs_healthy-controls_DOWN	NA	1872444
bsdb:292/1/1_graft-versus-host-disease:allogeneic-hematopoietic-stem-cell-transplant_vs_community-dwelling_UP	NA	316
bsdb:293/4/1_human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	134821
bsdb:293/4/2_human-papilloma-virus-infection:HPV+_vs_HPV-_DOWN	NA	287
bsdb:293/5/1_human-papilloma-virus-infection:new-acquisition-of-HPV-within-a-year_vs_no-new-acquisition-of-HPV-within-a-year_UP	NA	218538
bsdb:293/6/1_human-papilloma-virus-infection:without-any-HPV-type-cleared_vs_with-any-HPV-type-cleared-in-a-year_UP	NA	1763509
bsdb:293/7/1_human-papilloma-virus-infection:at-least-one-HPV-type-persisted_vs_no-HPV-type-persisted_UP	NA	1297424
bsdb:293/7/2_human-papilloma-virus-infection:at-least-one-HPV-type-persisted_vs_no-HPV-type-persisted_DOWN	NA	1584
bsdb:296/1/1_multiple-myeloma:multiple-myeloma_vs_health-control_UP	NA	351091
bsdb:296/1/2_multiple-myeloma:multiple-myeloma_vs_health-control_DOWN	NA	856
bsdb:296/2/1_multiple-myeloma:multiple-myeloma_vs_health-control_UP	NA	1313
bsdb:296/2/2_multiple-myeloma:multiple-myeloma_vs_health-control_DOWN	NA	84030
bsdb:299/1/1_acute-lymphoblastic-leukemia:induction-chemotherapy_vs_no-induction-chemotherapy_UP	NA	35783
bsdb:300/1/1_graft-versus-host-disease:acute-graft--versus--host-disease_vs_non--graft--versus--host-disease_UP	NA	43675
bsdb:300/1/2_graft-versus-host-disease:acute-graft--versus--host-disease_vs_non--graft--versus--host-disease_DOWN	NA	47678
bsdb:302/4/1_asthma:asthma_vs_healthy-control_UP	NA	208968
bsdb:302/5/1_asthma:asthma_vs_healthy-control_UP	NA	2702
bsdb:304/1/1_antimicrobial-agent:oral-intake-of-vancomycin-(directed-against-Gram-positive-bacteria)_vs_or-placebo-(microcrystalline-cellulose)_UP	NA	29343
bsdb:306/1/1_graft-versus-host-disease:post--allogeneic-hematopoietic-stem-cell-transplant_vs_pre--allogeneic-hematopoietic-stem-cell-transplant_UP	NA	303
bsdb:306/1/2_graft-versus-host-disease:post--allogeneic-hematopoietic-stem-cell-transplant_vs_pre--allogeneic-hematopoietic-stem-cell-transplant_DOWN	NA	303
bsdb:307/1/2_antimicrobial-agent:moxifloxacin-treated-group-(MXF)_vs_Negative-control-group-(CLT)_DOWN	NA	1318
bsdb:307/2/1_antimicrobial-agent:DAV132+moxifloxacin-treated-group-(MXF+DAV132)_vs_moxifloxacin-treated-group-(MXF)_UP	NA	1288121
bsdb:307/3/2_antimicrobial-agent:DAV132+moxifloxacin-treated-group-(MXF+DAV132)_vs_Negative-control-group-(CLT)_DOWN	NA	292800
bsdb:309/1/1_cervical-glandular-intraepithelial-neoplasia:CIN2+_vs_CIN1_UP	NA	28111
bsdb:309/3/1_cervical-glandular-intraepithelial-neoplasia:CIN2+_vs_CIN1_UP	NA	1598
bsdb:309/3/2_cervical-glandular-intraepithelial-neoplasia:CIN2+_vs_CIN1_DOWN	NA	239935
bsdb:314/2/1_cervical-glandular-intraepithelial-neoplasia:CIN-non-regression_vs_CIN-regression_UP	NA	2702
bsdb:314/3/1_cervical-glandular-intraepithelial-neoplasia:CIN-non-regression_vs_CIN-regression_UP	NA	386414
bsdb:314/4/1_cervical-glandular-intraepithelial-neoplasia:CIN-non-regression_vs_CIN-regression_UP	NA	87541
bsdb:320/1/1_antimicrobial-agent:infants(6-weeks)-to-mothers-exposed-to-intrapartum-antibiotic_vs_infants-(6-weeks)-to-mothers-unexposed-to--intrapartum-antibiotic_UP	NA	39778
bsdb:320/2/1_antimicrobial-agent:infants(1-year)-to-mothers-exposed-to-intrapartum-antibiotic_vs_infants-(1-year)-to-mothers-unexposed-to--intrapartum-antibiotic_UP	NA	39778
bsdb:320/4/1_antimicrobial-agent:infants(1-year)-to-mothers-exposed-to--antibiotics-(amoxicillin,-penicillin-or-ampicillin)_vs_infants-(1-year)-to-mothers-unexposed-to--antibiotic_UP	NA	33038
bsdb:320/5/1_antimicrobial-agent:infants(6-weeks)-to-mothers-exposed-to-multi-class-antibiotics_vs_infants-(6-weeks)-to-mothers-unexposed-to--antibiotic_UP	NA	39778
bsdb:324/1/2_thyroid-carcinoma:thyroid-carcinoma_vs_healthy-control_DOWN	NA	33038
bsdb:326/1/2_non-small-cell-lung-carcinoma,renal-cell-carcinoma:Responders_vs_Non-Responders_DOWN	NA	823
bsdb:326/2/1_non-small-cell-lung-carcinoma,renal-cell-carcinoma:Progressive--Free--Survival-more-than-30-days_vs_Progressive--Free--Survival-more-less-than-30-days_UP	NA	41978
bsdb:326/3/1_non-small-cell-lung-carcinoma,renal-cell-carcinoma:Responders_vs_Non-Responders_DOWN	NA	169292
bsdb:330/1/1_human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	147802
bsdb:330/2/1_human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	147802
bsdb:331/1/1_hashimoto's-thyroiditis:hashimoto's-thyroiditis-patients_vs_healthy-controls_UP	NA	42322
bsdb:332/1/1_hashimoto's-thyroiditis:hashimoto's-thyroiditis-patients_vs_healthy-controls_UP	NA	1265
bsdb:332/1/2_hashimoto's-thyroiditis:hashimoto's-thyroiditis-patients_vs_healthy-controls_DOWN	NA	1596
bsdb:337/2/1_antimicrobial-agent:3-month-old-infants-exposed_vs_not-exposed-to-antibiotics-during-the-second-trimester_DOWN	NA	227943
bsdb:338/2/1_obesity:obese_vs_normal-weight_UP	NA	33038
bsdb:346/1/1_unipolar-depression:severe-depression_vs_mild-depression_UP	NA	292800
bsdb:346/1/2_unipolar-depression:severe-depression_vs_mild-depression_DOWN	NA	847
bsdb:346/2/1_unipolar-depression:moderate-depression_vs_mild-depression_UP	NA	1512
bsdb:346/3/1_anxiety-disorder:severe-anxiety_vs_mild-anxiety_UP	NA	1328
bsdb:346/3/2_anxiety-disorder:severe-anxiety_vs_mild-anxiety_DOWN	NA	116085
bsdb:346/4/1_anxiety-disorder:moderate-anxiety_vs_mild-anxiety_UP	NA	1358
bsdb:347/1/1_obesity:obese_vs_control_UP	NA	847
bsdb:347/1/2_obesity:obese_vs_control_DOWN	NA	341220
bsdb:348/1/1_obesity:obese_vs_lean_UP	NA	1591
bsdb:348/1/2_obesity:obese_vs_lean_DOWN	NA	41200
bsdb:348/2/1_obesity:overweight_vs_lean_UP	NA	1591
bsdb:348/2/2_obesity:overweight_vs_lean_DOWN	NA	41200
bsdb:348/3/1_obesity:obese_vs_lean_UP	NA	817
bsdb:348/3/2_obesity:obese_vs_lean_DOWN	NA	41200
bsdb:348/4/1_obesity:overweight_vs_lean_UP	NA	1591
bsdb:349/1/1_cervical-glandular-intraepithelial-neoplasia:LEEP-group-before-prcocedure_vs_normal_UP	NA	134821
bsdb:349/2/1_cervical-glandular-intraepithelial-neoplasia:LEEP-group-before-prcocedure_vs_normal_UP	NA	134821
bsdb:349/3/1_cervical-glandular-intraepithelial-neoplasia:LEEP-group-before-prcocedure_vs_normal_UP	NA	134821
bsdb:349/4/1_cervical-glandular-intraepithelial-neoplasia:LEEP-group-before-prcocedure_vs_normal_UP	NA	134821
bsdb:349/5/1_cervical-glandular-intraepithelial-neoplasia:LEEP-group-6-months-prcocedure_vs_normal_UP	NA	134821
bsdb:349/6/1_cervical-glandular-intraepithelial-neoplasia:LEEP-group-12-months-prcocedure_vs_normal_UP	NA	134821
bsdb:350/1/1_obesity:obese_vs_normal-weight_UP	NA	853
bsdb:353/1/1_obesity:obese_vs_non-obese_UP	NA	853
bsdb:355/1/1_obesity:obese-(obese/overweight/morbidly-obese)_vs_control-(lean/normal-weight)_UP	NA	1591
bsdb:355/1/2_obesity:obese-(obese/overweight/morbidly-obese)_vs_control-(lean/normal-weight)_DOWN	NA	821
bsdb:356/1/2_air-pollution:ICR-male-mice-exposed-to-PM-2.5_vs_mice-dams-exposed-to-filtered-blanks-PND-3_DOWN	NA	1940338
bsdb:358/1/1_cervical-glandular-intraepithelial-neoplasia,cervical-cancer:CIN2/3-CC_vs_Healthy-controls_UP	NA	286638
bsdb:364/1/1_smoking-behavior:smoker_vs_non-smoker_UP	NA	39777
bsdb:367/1/1_obesity:obese_vs_normal-weight_UP	NA	2049040
bsdb:367/2/1_obesity:overweight_vs_normal-weight_UP	NA	2049040
bsdb:368/1/1_smoking-behavior:shammah-users_vs_non-shammah-users_UP	NA	495
bsdb:371/1/1_obesity:obese_vs_lean_UP	NA	1591
bsdb:371/2/1_obesity:obese_vs_lean_DOWN	NA	2173
bsdb:371/3/1_obesity:obese_vs_lean_DOWN	NA	562
bsdb:371/4/1_obesity:obese_vs_lean_UP	NA	1598
bsdb:373/1/1_obesity:overweight_vs_normal-weight-children_UP	NA	1681
bsdb:373/1/2_obesity:overweight_vs_normal-weight-children_DOWN	NA	239935
bsdb:373/2/1_obesity:overweight_vs_normal-weight-adult_UP	NA	1680
bsdb:373/2/2_obesity:overweight_vs_normal-weight-adult_DOWN	NA	88431
bsdb:375/1/2_obesity:obese_vs_normal-weight_DOWN	NA	562
bsdb:376/2/1_antimicrobial-agent:patients-that-took-levofloxacin/Metronidazole_vs_before-antibiotic-exposure_UP	NA	310297
bsdb:377/1/1_smoking-behavior:never-smoker_vs_E-cigarette-smoker_UP	NA	2049038
bsdb:377/1/2_smoking-behavior:never-smoker_vs_E-cigarette-smoker_DOWN	NA	39778
bsdb:377/2/1_smoking-behavior:never-smoker_vs_cigarette-smoker_UP	NA	192066
bsdb:377/3/1_smoking-behavior:E-cigarette-smoker_vs_cigarette-smoker_UP	NA	2049038
bsdb:377/3/2_smoking-behavior:E-cigarette-smoker_vs_cigarette-smoker_DOWN	NA	1318
bsdb:379/1/1_obesity:non-obese_vs_obese_UP	NA	227945
bsdb:379/2/1_obesity:obese_vs_non-obese_UP	NA	29317
bsdb:382/1/1_chlamydia-trachomatis-infectious-disease:patient-with-chlamydia-infection_vs_healthy-control_UP	NA	87541
bsdb:382/2/1_human-papilloma-virus-infection,Chlamydophila-infectious-disease:patient-with-chlamydia-infection_vs_HPV-positive-women_UP	NA	813
bsdb:385/1/2_gastric-adenocarcinoma:gastric-adenocarcinoma-(GC)_vs_superficial-gastritis-(SG)_DOWN	NA	1318
bsdb:386/1/1_pulmonary-tuberculosis:Tuberculosis-(TB)-patients_vs_healthy-controls_UP	NA	208479
bsdb:386/1/2_pulmonary-tuberculosis:Tuberculosis-(TB)-patients_vs_healthy-controls_DOWN	NA	46228
bsdb:397/1/1_atopic-eczema:severe-atopic-dermatitis_vs_healthy-control_UP	NA	172044
bsdb:397/1/2_atopic-eczema:severe-atopic-dermatitis_vs_healthy-control_DOWN	NA	425941
bsdb:403/4/1_eczema:child-with-eczema_vs_healthy-control_UP	NA	817
bsdb:403/4/2_eczema:child-with-eczema_vs_healthy-control_DOWN	NA	1681
bsdb:416/1/1_HIV-infection,cotrimoxazole:continue-cotrimoxazole-prophylaxis_vs_stop-cotrimoxazole-prophylaxis_UP	NA	28118
bsdb:416/1/2_HIV-infection,cotrimoxazole:continue-cotrimoxazole-prophylaxis_vs_stop-cotrimoxazole-prophylaxis_DOWN	NA	1318
bsdb:416/1/3_HIV-infection,cotrimoxazole:continue-cotrimoxazole-prophylaxis_vs_stop-cotrimoxazole-prophylaxis_UP	NA	166486
bsdb:416/1/4_HIV-infection,cotrimoxazole:continue-cotrimoxazole-prophylaxis_vs_stop-cotrimoxazole-prophylaxis_DOWN	NA	1343
bsdb:428/1/1_COVID-19:COVID-19-cases_vs_Healthy-controls_UP	NA	239935
bsdb:428/1/2_COVID-19:COVID-19-cases_vs_Healthy-controls_DOWN	NA	39486
bsdb:428/2/1_COVID-19:Recovered-COVID-19-cases_vs_Healthy-controls_UP	NA	1512
bsdb:428/3/1_COVID-19:Recovered-COVID-19-cases_vs_Healthy-controls_UP	NA	29466
bsdb:428/3/2_COVID-19:Recovered-COVID-19-cases_vs_Healthy-controls_DOWN	NA	39488
bsdb:428/4/1_COVID-19:COVID-19-patients-treated-with-antibiotics_vs_Healthy-controls_DOWN	NA	1896336
bsdb:428/4/2_COVID-19:COVID-19-patients-treated-with-antibiotics_vs_Healthy-controls_UP	NA	1869337
bsdb:430/1/1_COVID-19:Patients-with-high-SARS-CoV-2-infectivity_vs_Patients-with-low-to-none-SARS-CoV-2-infectivity_UP	NA	1898203
bsdb:430/1/2_COVID-19:Patients-with-high-SARS-CoV-2-infectivity_vs_Patients-with-low-to-none-SARS-CoV-2-infectivity_DOWN	NA	626935
bsdb:434/1/2_human-papilloma-virus-infection:HPV-+_vs_healthy-control_DOWN	NA	82135
bsdb:434/2/1_cervical-glandular-intraepithelial-neoplasia:LSIL_vs_healthy-control_UP	NA	419005
bsdb:434/2/2_cervical-glandular-intraepithelial-neoplasia:LSIL_vs_healthy-control_DOWN	NA	82135
bsdb:434/3/1_cervical-glandular-intraepithelial-neoplasia:HSIL_vs_healthy-control_UP	NA	386414
bsdb:434/3/2_cervical-glandular-intraepithelial-neoplasia:HSIL_vs_healthy-control_DOWN	NA	82135
bsdb:434/4/1_cervical-cancer:cervical-cancer_vs_healthy-control_UP	NA	281920
bsdb:434/4/2_cervical-cancer:cervical-cancer_vs_healthy-control_DOWN	NA	82135
bsdb:435/2/1_human-papilloma-virus-infection:HPV+-transient_vs_HPV-_UP	NA	147802
bsdb:436/1/1_cervical-glandular-intraepithelial-neoplasia:CIN2+/cervical-cancer_vs_healthy-control_UP	NA	386414
bsdb:437/1/1_human-papilloma-virus-infection:HPV-16+_vs_healthy-control_UP	NA	2702
bsdb:440/1/1_Rosacea:Participants-with-papulopustular-rosacea-(PPR)_vs_Healthy-controls_UP	NA	28131
bsdb:440/1/2_Rosacea:Participants-with-papulopustular-rosacea-(PPR)_vs_Healthy-controls_DOWN	NA	38313
bsdb:440/2/1_rosacea:Participants-with-erythematotelangiectatic-rosacea_vs_Healthy-controls_DOWN	NA	33038
bsdb:441/2/1_Influenza-A-(H1N1):H1N1-cases_vs_Healthy-controls_DOWN	NA	41978
bsdb:442/1/1_type-II-diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_DOWN	NA	29918
bsdb:442/1/2_type-II-diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_UP	NA	5551
bsdb:443/1/1_irritable-bowel-syndrome:IBS_vs_Health-Control_UP	NA	287
bsdb:443/2/2_irritable-bowel-syndrome:IBS-C_vs_Health-Control_DOWN	NA	1686
bsdb:443/3/1_irritable-bowel-syndrome:IBS-D_vs_Health-Control_UP	NA	287
bsdb:443/3/2_irritable-bowel-syndrome:IBS-D_vs_Health-Control_DOWN	NA	1686
bsdb:443/4/1_irritable-bowel-syndrome:IBS-U_vs_Health-Control_UP	NA	287
bsdb:446/1/1_COVID-19:COVID-19-cases_vs_COVID-19-negative-controls_DOWN	NA	38284
bsdb:449/1/1_COVID-19:COVID-19-cases_vs_Healthy-controls_UP	NA	55601
bsdb:449/1/2_COVID-19:COVID-19-cases_vs_Healthy-controls_DOWN	NA	221027
bsdb:453/3/1_COVID-19:Recovered-COVID-19-patients_vs_Non-infected-patients-with-unrelated-respiratory-medical-conditions_UP	NA	877428
bsdb:455/3/1_gingivitis:pregnant-women-with-gingivitis_vs_pregnant-women-without-gingivitis_UP	NA	2699746
bsdb:455/3/2_gingivitis:pregnant-women-with-gingivitis_vs_pregnant-women-without-gingivitis_DOWN	NA	1382
bsdb:455/4/1_Pregnancy:pregnant-women_vs_non-pregnant-women_UP	NA	51123
bsdb:455/4/2_Pregnancy:pregnant-women_vs_non-pregnant-women_DOWN	NA	217202
bsdb:457/1/1_periodontitis:Individuals-diagnosed-with-Periodontitis_vs_Healthy-controls_UP	NA	58231
bsdb:457/2/1_periodontitis:Individuals-diagnosed-with-Periodontitis-and-Type-2-Diabetes-Mellitus-(DAP)_vs_Healthy-controls_UP	NA	234908
bsdb:457/4/1_periodontitis:Individuals-diagnosed-with-both-Periodontitis-and-Type-2-Diabetes-and-treated-with-metformin-(Met-group)_vs_Healthy-controls_UP	NA	58231
bsdb:457/5/1_periodontitis:Individuals-diagnosed-with-both-Periodontitis-and-Type-2-Diabetes-and-treated-with-metformin-(Met-group)_vs_Individuals-diagnosed-with-Periodontitis-and-Type-2-Diabetes-Mellitus-(DAP)_DOWN	NA	234908
bsdb:457/5/2_periodontitis:Individuals-diagnosed-with-both-Periodontitis-and-Type-2-Diabetes-and-treated-with-metformin-(Met-group)_vs_Individuals-diagnosed-with-Periodontitis-and-Type-2-Diabetes-Mellitus-(DAP)_UP	NA	1309
bsdb:464/3/1_COVID-19:COVID-19-patients_vs_Healthy-controls_DOWN	NA	707003
bsdb:465/1/1_diabetic-neuropathy:Individuals-diagnosed-with-peripheral-neuropathy-associated-with-type-2-diabetes_vs_Healthy-controls_UP	NA	1940338
bsdb:468/4/1_endometriosis:Stage-3/4-endometriosis-patients_vs_Healthy-controls_UP	NA	1940338
bsdb:468/5/1_endometriosis:Stage-3/4-endometriosis-patients_vs_Healthy-controls_UP	NA	1940338
bsdb:469/1/1_COVID-19:COVID-19-patients_vs_Non-COVID-19-controls_DOWN	NA	40324
bsdb:470/1/1_colorectal-cancer:colorectal-cancer_vs_controls_UP	NA	33039
bsdb:470/1/3_colorectal-cancer:colorectal-cancer_vs_controls_UP	NA	1904861
bsdb:471/1/1_colorectal-cancer:colorectal-cancer-cases_vs_controls_UP	NA	33039
bsdb:471/1/2_colorectal-cancer:colorectal-cancer-cases_vs_controls_DOWN	NA	1686
bsdb:471/1/3_colorectal-cancer:colorectal-cancer-cases_vs_controls_UP	NA	1077464
bsdb:471/1/4_colorectal-cancer:colorectal-cancer-cases_vs_controls_DOWN	NA	113107
bsdb:472/1/1_gestational-diabetes:Pregnant-individuals-with-gestational-diabetes_vs_Pregnant-individuals-who-are-normal-glucose-tolerance-(NGT)]_UP	NA	36835
bsdb:477/2/2_COVID-19:Severe-COVID-19-patients-requiring-ICU_vs_COVID-19-negative-controls_DOWN	NA	172788
bsdb:478/1/1_COVID-19:COVID-19-patients_vs_Healthy-controls_DOWN	NA	1750
bsdb:478/1/2_COVID-19:COVID-19-patients_vs_Healthy-controls_UP	NA	82688
bsdb:478/2/1_COVID-19:COVID-19-patients_vs_Flu-patients_DOWN	NA	1750
bsdb:478/3/1_COVID-19:Flu-patients_vs_Healthy-controls_UP	NA	419005
bsdb:478/3/2_COVID-19:Flu-patients_vs_Healthy-controls_DOWN	NA	1750
bsdb:481/1/1_COVID-19:COVID-19-patients_vs_Healthy-controls_UP	NA	658655
bsdb:481/1/2_COVID-19:COVID-19-patients_vs_Healthy-controls_DOWN	NA	204516
bsdb:481/2/1_COVID-19:Antibiotic-treated-COVID-19-patients_vs_Antibiotic-naive-COVID-19-patients_UP	NA	1547
bsdb:481/2/2_COVID-19:Antibiotic-treated-COVID-19-patients_vs_Antibiotic-naive-COVID-19-patients_DOWN	NA	821
bsdb:481/3/1_COVID-19:Severe-COVID-19-patients_vs_Mild-COVID-19-patients_UP	NA	187326
bsdb:481/3/2_COVID-19:Severe-COVID-19-patients_vs_Mild-COVID-19-patients_DOWN	NA	39491
bsdb:483/1/1_COVID-19:Antibiotic-naive-COVID-19-patients_vs_Uninfected-controls,-pneumonia-patients,-antibiotics-treated-COVID-19-patients_UP	NA	291645
bsdb:483/1/2_COVID-19:Antibiotic-naive-COVID-19-patients_vs_Uninfected-controls,-pneumonia-patients,-antibiotics-treated-COVID-19-patients_DOWN	NA	39496
bsdb:483/2/1_COVID-19:Antibiotic-treated-COVID-19-patients_vs_Antibiotic-naive-COVID-19-patients,-pneumonia-patients,-uninfected-controls_DOWN	NA	39496
bsdb:483/3/1_COVID-19:Pneumonia-controls_vs_Uninfected-controls,-COVID-19-patients_DOWN	NA	39496
bsdb:484/1/1_COVID-19:COVID-19-positive-patients_vs_COVID-19-negative-patients-with-fever-and-cough_UP	NA	59823
bsdb:484/4/1_COVID-19:COVID-19-positive-patients_vs_COVID-19-negative-patients-with-fever-and-cough_UP	NA	1311
bsdb:485/2/1_COVID-19:COVID-19-patients-with-fever_vs_COVID-19-patients-without-fever_UP	NA	1351
bsdb:485/2/2_COVID-19:COVID-19-patients-with-fever_vs_COVID-19-patients-without-fever_DOWN	NA	658082
bsdb:486/1/1_COVID-19:Asymptomatic-COVID-19-patients_vs_Healthy-controls_UP	NA	1587
bsdb:486/1/2_COVID-19:Asymptomatic-COVID-19-patients_vs_Healthy-controls_DOWN	NA	1531
bsdb:486/2/1_COVID-19:Asymptomatic-COVID-19-patients_vs_Healthy-controls_UP	NA	358743
bsdb:486/3/1_COVID-19:Severe-COVID-19-patients_vs_Healthy-controls_UP	NA	622
bsdb:489/1/1_COVID-19:COVID-positive-patients-admitted-to-ICU-(i-COVID-19)_vs_Pneumonia-control-patients-(COVID-negative)_UP	NA	1720
bsdb:489/2/1_COVID-19:COVID-positive-patients-admitted-to-ICU-(i-COVID-19)_vs_COVID-positive-patients-admitted-to-infectious-disease-ward-(w-COVID-19)_UP	NA	1282
bsdb:489/2/2_COVID-19:COVID-positive-patients-admitted-to-ICU-(i-COVID-19)_vs_COVID-positive-patients-admitted-to-infectious-disease-ward-(w-COVID-19)_DOWN	NA	550
bsdb:489/3/1_COVID-19:COVID-positive-patients-admitted-to-infectious-disease-ward-(w-COVID-19)_vs_Pneumonia-controls-(COVID-negative)_UP	NA	29387
bsdb:489/3/2_COVID-19:COVID-positive-patients-admitted-to-infectious-disease-ward-(w-COVID-19)_vs_Pneumonia-controls-(COVID-negative)_DOWN	NA	818
bsdb:498/1/1_COVID-19:COVID-19-patients_vs_Asymptomatic-uninfected-controls_UP	NA	821
bsdb:498/1/2_COVID-19:COVID-19-patients_vs_Asymptomatic-uninfected-controls_DOWN	NA	28130
bsdb:498/2/1_COVID-19:COVID-19-patients-with-high-viral-load_vs_COVID-19-patients-with-low-viral-load_UP	NA	165179
bsdb:498/2/2_COVID-19:COVID-19-patients-with-high-viral-load_vs_COVID-19-patients-with-low-viral-load_DOWN	NA	1283
bsdb:499/1/2_irritable-bowel-syndrome:IBS-A_vs_Healthy-Control_UP	NA	244328
bsdb:499/2/1_irritable-bowel-syndrome:IBS-C_vs_Healthy-Control_DOWN	NA	152509
bsdb:499/2/2_irritable-bowel-syndrome:IBS-C_vs_Healthy-Control_UP	NA	33038
bsdb:499/3/2_irritable-bowel-syndrome:IBS-D_vs_Healthy-Control_UP	NA	46228
bsdb:499/4/1_irritable-bowel-syndrome:IBS-(All-patients)_vs_Healthy-Control_DOWN	NA	244328
bsdb:499/4/2_irritable-bowel-syndrome:IBS-(All-patients)_vs_Healthy-Control_UP	NA	46228
bsdb:500/1/1_COVID-19:COVID-19-patients_vs_Non-COVID-19-pneumonia-patients_UP	NA	43263
bsdb:502/1/1_irritable-bowel-syndrome:IBS_vs_Healthy-Control_UP	NA	39491
bsdb:502/3/1_irritable-bowel-syndrome:IBS-D_vs_Healthy-Control_UP	NA	39491
bsdb:502/4/1_irritable-bowel-syndrome:IBS-M_vs_Healthy-Control_UP	NA	1581
bsdb:505/1/1_irritable-bowel-syndrome:IBS_vs_Healthy-Control_UP	NA	216816
bsdb:505/1/2_irritable-bowel-syndrome:IBS_vs_Healthy-Control_DOWN	NA	1680
bsdb:505/2/1_irritable-bowel-syndrome:IBS-D_vs_Healthy-Control_UP	NA	216816
bsdb:505/2/2_irritable-bowel-syndrome:IBS-D_vs_Healthy-Control_DOWN	NA	1681
bsdb:505/3/1_irritable-bowel-syndrome:IBS-A_vs_Healthy-Control_UP	NA	1681
bsdb:505/3/2_irritable-bowel-syndrome:IBS-A_vs_Healthy-Control_DOWN	NA	216816
bsdb:505/4/1_irritable-bowel-syndrome:IBS-C_vs_Healthy-Control_UP	NA	1681
bsdb:505/4/2_irritable-bowel-syndrome:IBS-C_vs_Healthy-Control_DOWN	NA	216816
bsdb:506/1/1_irritable-bowel-syndrome:IBS-D_vs_Healthy-Control_UP	NA	562
bsdb:510/1/1_periodontitis:patients-with-rheumatoid-arthritis_vs_patients-with-no-rheumatoid-arthritis_UP	NA	1872413
bsdb:510/1/2_periodontitis:patients-with-rheumatoid-arthritis_vs_patients-with-no-rheumatoid-arthritis_DOWN	NA	166
bsdb:510/2/1_rheumatoid-arthritis:patients-with-rheumatoid-arthritis_vs_patients-with-no-rheumatoid-arthritis_UP	NA	712711
bsdb:510/2/2_rheumatoid-arthritis:patients-with-rheumatoid-arthritis_vs_patients-with-no-rheumatoid-arthritis_DOWN	NA	325787
bsdb:511/1/2_COVID-19:COVID-19-patients_vs_Healthy-controls_DOWN	NA	59892
bsdb:511/3/2_COVID-19:COVID-19-patients-not-treated-with-antibiotics_vs_Healthy-controls_DOWN	NA	28131
bsdb:511/4/2_COVID-19:COVID-19-patients_vs_Healthy-controls_DOWN	NA	387090
bsdb:512/2/1_COVID-19:COVID-19-positive-patients_vs_COVID-19-negative-controls_UP	NA	287
bsdb:512/3/1_COVID-19:COVID-19-positive-patients_vs_COVID-19-negative-healthcare-workers-(controls)_UP	NA	287
bsdb:512/3/2_COVID-19:COVID-19-positive-patients_vs_COVID-19-negative-healthcare-workers-(controls)_DOWN	NA	292
bsdb:522/2/1_endometriosis:Endometriosis-patients_vs_Controls-undergoing-laparoscopic-surgery-for-benign-tumors_DOWN	NA	147802
bsdb:522/3/1_endometriosis:Endometriosis-patients_vs_Controls-undergoing-laparoscopic-surgery-for-benign-tumors_UP	NA	33069
bsdb:522/3/2_endometriosis:Endometriosis-patients_vs_Controls-undergoing-laparoscopic-surgery-for-benign-tumors_DOWN	NA	33069
bsdb:522/4/2_endometriosis:Endometriosis-patients_vs_Controls-undergoing-laparoscopic-surgery-for-benign-tumors_DOWN	NA	128780
bsdb:522/5/1_endometriosis:Endometriosis-patients_vs_Controls-undergoing-laparoscopic-surgery-for-benign-tumors_UP	NA	28454
bsdb:522/5/2_endometriosis:Endometriosis-patients_vs_Controls-undergoing-laparoscopic-surgery-for-benign-tumors_DOWN	NA	296
bsdb:525/1/2_endometriosis:Women-with-EM-associated-CPPS_vs_Women-without-CPPS-presenting-for-routine-examinations_UP	NA	180282
bsdb:525/2/1_endometriosis:Women-with-EM-associated-CPPS_vs_Women-without-CPPS-presenting-for-routine-examinations_UP	NA	187328
bsdb:525/2/2_endometriosis:Women-with-EM-associated-CPPS_vs_Women-without-CPPS-presenting-for-routine-examinations_DOWN	NA	109790
bsdb:535/1/1_Antimicrobial-agent:Antibiotic-treated_vs_Antibiotic-untreated_DOWN	NA	41200
bsdb:535/1/2_Antimicrobial-agent:Antibiotic-treated_vs_Antibiotic-untreated_UP	NA	1591
bsdb:536/1/1_Azithromycin:The-group-given-an-azithromycin-oral-solution_vs_The-group-given-a-placebo_DOWN	NA	165187
bsdb:541/1/1_schizophrenia:Schizophrenic-patients-(ARSCZ,-FESCZ)_vs_Healthy-controls_UP	NA	1613
bsdb:541/1/2_schizophrenia:Schizophrenic-patients-(ARSCZ,-FESCZ)_vs_Healthy-controls_UP	NA	1632
bsdb:541/2/1_schizophrenia:Schizophrenic-patients-(ARSCZ,-FESCZ)_vs_Healthy-controls_UP	NA	310297
bsdb:541/2/2_schizophrenia:Schizophrenic-patients-(ARSCZ,-FESCZ)_vs_Healthy-controls_DOWN	NA	1244
bsdb:541/2/3_schizophrenia:Schizophrenic-patients-(ARSCZ,-FESCZ)_vs_Healthy-controls_UP	NA	1613
bsdb:541/3/1_schizophrenia:Schizophrenic-patients_vs_Healthy-controls_UP	NA	310297
bsdb:541/3/2_schizophrenia:Schizophrenic-patients_vs_Healthy-controls_DOWN	NA	357276
bsdb:541/4/1_schizophrenia:Baseline-schizophrenic-patients_vs_Healthy-controls_NA	NA	310297
bsdb:541/5/1_schizophrenia:Baseline-schizophrenic-patients_vs_Healthy-controls_NA	NA	310297
bsdb:545/1/2_Antimicrobial-agent:7-week-old-(young)-mice-10-days-after-antibiotic-treatments_vs_7-week-old-(young)-mice-before-antibiotic-treatment_DOWN	NA	1898207
bsdb:545/4/1_antimicrobial-agent:40-week-old-(old)-mice-6-months-after-antibiotic-treatments_vs_40-week-old-(old)-mice-before-antibiotic-treatment_DOWN	NA	1898207
bsdb:547/1/1_COVID-19:Recovered-COVID-19-patients_vs_Healthy-controls_UP	NA	208479
bsdb:547/1/2_COVID-19:Recovered-COVID-19-patients_vs_Healthy-controls_DOWN	NA	1150298
bsdb:550/1/1_juvenile-idiopathic-arthritis:JIA-patients_vs_healthy-controls_UP	NA	712365
bsdb:550/1/2_juvenile-idiopathic-arthritis:JIA-patients_vs_healthy-controls_DOWN	NA	712464;712187
bsdb:550/2/2_temporomandibular-joint-disorder:JIA-patients-with-TMJ_vs_JIA-patients-without-TMJ_UP	NA	729
bsdb:553/1/1_spontaneous-abortion:First-or-second-trimester-miscarriage_vs_Viable-control-pregnancy_DOWN	NA	1591
bsdb:553/2/1_spontaneous-abortion:First-trimester-miscarriage_vs_Viable-control-pregnancy_DOWN	NA	1591
bsdb:553/3/1_spontaneous-abortion:complete/incomplete-miscarriage_vs_missed-miscarriage_DOWN	NA	1591
bsdb:561/1/2_Parkinson's-disease:Participants-with-early-stage-Parkinson's-Disease._vs_Healthy-age-sex-matched-controls-without-Parkinson's-disease._DOWN	NA	1790137
bsdb:562/3/2_NA:feces-from-healthy-adult_vs_none---50%-prevalence-threshold_NA	NA	4628
bsdb:562/3/3_NA:feces-from-healthy-adult_vs_none---50%-prevalence-threshold_NA	NA	4628
bsdb:562/4/2_NA:nasal-cavity-from-healthy-adult_vs_none---50%-prevalence-threshold_NA	NA	33011
bsdb:562/5/2_NA:oral-cavity-from-healthy-adult_vs_none---50%-prevalence-threshold_NA	NA	28129
